| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The present study investigated the mechanisms involved in the mitogenic action of epidermal growth factor (EGF) in cultured human myometrial smooth muscle cells. The cells contained EGF/transforming growth factor-
(TGF-) receptors as well as EGF and TGF- mRNA transcripts and the corresponding proteins. Culturing with human EGF resulted in concentration- and time-dependent increases in cell density. The maximal increase was seen at 1 nM followed by a decrease to control levels at 100 nM EGF. The EGF increased cell density from 4 to 8 days followed by a plateau coinciding with the cells reaching confluence. EGF treatment concomitantly decreased the average size of cells. TGF- mimicked EGF and there was no synergism between the two, suggesting a common mechanism of action. Although the presence of 10% fetal bovine serum enhanced overall cell growth, it was not required for EGF and TGF- action. The receptor antibody, which is directed against the extracellular domain and can inhibit ligand binding to the receptors, dramatically inhibited the basal cell growth and exogenous EGF reversed the antibody effect. While TGF- antibody was only marginally effective, EGF antibody had no effect on basal cell growth. Lavendustin (a tyrosine kinase inhibitor), calphostin (a protein kinase C inhibitor), but not H-89 (a protein kinase A inhibitor), inhibited EGF action. Indomethacin, a cyclo-oxygenase inhibitor, completely inhibited, whereas nordihydroguaiaretic acid, a lipoxygenase inhibitor, slightly inhibited EGF action. While estradiol-17β modestly inhibited basal as well as EGF-stimulated myometrial smooth muscle cell density, progesterone had no effect.
In summary, mitogenic action of EGF in human myometrial smooth muscle cells does not require serum components and it involves tyrosine kinase and protein kinase C signaling and eicosanoids from the cyclo-oxygenase pathway of arachidonic acid metabolism.
Journal of Endocrinology (1995) 146, 261–270
This article has been cited by other articles:
|
|
 |
|
  P. Ciarmela, E. Wiater, S. M. Smith, and W. Vale Presence, Actions, and Regulation of Myostatin in Rat Uterus and Myometrial Cells Endocrinology, February 1, 2009; 150(2): 906 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Soloff, Y.-J. Jeng, M. Ilies, S. L. Soloff, M. G. Izban, T. G. Wood, N. I. Panova, G. V.N. Velagaleti, and G. D. Anderson Immortalization and characterization of human myometrial cells from term-pregnant patients using a telomerase expression vector Mol. Hum. Reprod., September 1, 2004; 10(9): 685 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Robin, I. Boulven, C. Bole-Feysot, Z. Tanfin, and D. Leiber Contribution of PKC-dependent and -independent processes in temporal ERK regulation by ET-1, PDGF, and EGF in rat myometrial cells Am J Physiol Cell Physiol, April 1, 2004; 286(4): C798 - C806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Haug, A. Schmid-Kotsas, T. Linder, M. G. Bachem, A. Gruenert, and E. Rozdzinski Influence of hepatocyte growth factor, epidermal growth factor, and mycophenolic acid on endothelin-1 synthesis in human endothelial cells Nephrol. Dial. Transplant., December 1, 2001; 16(12): 2310 - 2316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tohda, K. Oida, Y. Okada, S. Kosaka, E. Okada, S. Takahashi, H. Ishii, and I. Miyamori Expression of Thrombomodulin in Atherosclerotic Lesions and Mitogenic Activity of Recombinant Thrombomodulin in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1861 - 1869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Gargiulo, F. S. Khan-Dawood, and M. Y. Dawood Epidermal Growth Factor Receptors in Uteroplacental Tissues in Term Pregnancy before and after the Onset of Labor J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 113 - 117. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
